HHF1
MCID: HYP304
MIFTS: 39

Hyperinsulinemic Hypoglycemia, Familial, 1 (HHF1) malady

Categories: Genetic diseases, Endocrine diseases, Rare diseases, Metabolic diseases

Aliases & Classifications for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Aliases & Descriptions for Hyperinsulinemic Hypoglycemia, Familial, 1:

Name: Hyperinsulinemic Hypoglycemia, Familial, 1 52 12 68
Persistent Hyperinsulinemic Hypoglycemia of Infancy 70 27
Congenital Hyperinsulinism 70 68
Hyperinsulinemic Hypoglycemia Due to Sur1 Deficiency, Diazoxide-Resistant Focal Form 54
Autosomal Recessive Hyperinsulinemic Hypoglycemia Due to Sur1 Deficiency 54
Autosomal Dominant Hyperinsulinemic Hypoglycemia Due to Sur1 Deficiency 54
 
Diazoxide-Resistant Focal Hyperinsulinism Due to Sur1 Deficiency 54
Autosomal Recessive Hyperinsulinism Due to Sur1 Deficiency 54
Autosomal Dominant Hyperinsulinism Due to Sur1 Deficiency 54
Familial Hyperinsulinemic Hypoglycemia 1 70
Phhi 70
Hhf1 70

Characteristics:

Orphanet epidemiological data:

54
autosomal dominant hyperinsulinemic hypoglycemia due to sur1 deficiency:
Inheritance: Autosomal dominant; Age of onset: Infancy,Neonatal
hyperinsulinemic hypoglycemia due to sur1 deficiency, diazoxide-resistant focal form:
Inheritance: Autosomal dominant,Autosomal recessive; Age of onset: Infancy,Neonatal

HPO:

64
hyperinsulinemic hypoglycemia, familial, 1:
Inheritance: autosomal dominant inheritance, autosomal recessive inheritance, heterogeneous

Classifications:



External Ids:

OMIM52 256450
ICD10 via Orphanet31 E16.1
MedGen37 C1257959

Summaries for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section
OMIM:52 Familial hyperinsulinism, also referred to as congenital hyperinsulinism, nesidioblastosis, or persistent... (256450) more...

MalaCards based summary: Hyperinsulinemic Hypoglycemia, Familial, 1, also known as persistent hyperinsulinemic hypoglycemia of infancy, is related to hyperinsulinemic hypoglycemia, familial, 5 and hyperinsulinemic hypoglycemia, familial, 2, and has symptoms including Array, Array and Array. An important gene associated with Hyperinsulinemic Hypoglycemia, Familial, 1 is ABCC8 (ATP Binding Cassette Subfamily C Member 8). Affiliated tissues include brain and pancreatic islet.

Genetics Home Reference:25 Congenital hyperinsulinism is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps control blood sugar levels. People with this condition have frequent episodes of low blood sugar (hypoglycemia). In infants and young children, these episodes are characterized by a lack of energy (lethargy), irritability, or difficulty feeding. Repeated episodes of low blood sugar increase the risk for serious complications such as breathing difficulties, seizures, intellectual disability, vision loss, brain damage, and coma.

UniProtKB/Swiss-Prot:70 Familial hyperinsulinemic hypoglycemia 1: Most common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur.

Related Diseases for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Graphical network of diseases related to Hyperinsulinemic Hypoglycemia, Familial, 1:



Diseases related to hyperinsulinemic hypoglycemia, familial, 1

Symptoms & Phenotypes for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Symptoms by clinical synopsis from OMIM:

256450

Clinical features from OMIM:

256450

Human phenotypes related to Hyperinsulinemic Hypoglycemia, Familial, 1:

 54 64 (show all 29)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 microcephaly64 54 Frequent (79-30%) HP:0000252
2 agitation64 54 Occasional (29-5%) HP:0000713
3 global developmental delay64 54 Occasional (29-5%) HP:0001263
4 hyperinsulinemic hypoglycemia64 54 Very frequent (99-80%) HP:0000825
5 hyperinsulinemia54 Very frequent (99-80%)
6 hyperhidrosis64 54 Very frequent (99-80%) HP:0000975
7 pallor64 54 Very frequent (99-80%) HP:0000980
8 seizures64 54 Occasional (29-5%) HP:0001250
9 lethargy64 54 Very frequent (99-80%) HP:0001254
10 coma64 54 Very frequent (99-80%) HP:0001259
11 hepatomegaly64 54 Frequent (79-30%) HP:0002240
12 large for gestational age64 54 Occasional (29-5%) HP:0001520
13 tachycardia64 54 Very frequent (99-80%) HP:0001649
14 hypoketotic hypoglycemia64 54 Very frequent (99-80%) HP:0001985
15 neonatal hypoglycemia64 54 Very frequent (99-80%) HP:0001998
16 vomiting64 54 Frequent (79-30%) HP:0002013
17 diarrhea64 54 Frequent (79-30%) HP:0002014
18 drowsiness64 54 Occasional (29-5%) HP:0002329
19 progressive neurologic deterioration64 54 Very frequent (99-80%) HP:0002344
20 decreased circulating cortisol level64 54 Occasional (29-5%) HP:0008163
21 abnormality of fatty-acid metabolism64 54 Very frequent (99-80%) HP:0004359
22 pancreatic islet-cell hyperplasia64 54 Very frequent (99-80%) HP:0004510
23 vitamin b1 deficiency64 54 Frequent (79-30%) HP:0100503
24 cognitive impairment54 Frequent (79-30%)
25 secondary growth hormone deficiency64 54 Occasional (29-5%) HP:0008240
26 abnormal brain fdg positron emission tomography64 54 Occasional (29-5%) HP:0012658
27 intellectual disability64 HP:0001249
28 hypoglycemic coma64 HP:0001325
29 hypoglycemic seizures64 HP:0002173

Drugs & Therapeutics for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Drugs for Hyperinsulinemic Hypoglycemia, Familial, 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 108)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SomatostatinapprovedPhase 4, Phase 223738916-34-6, 51110-01-153481605
Synonyms:
growth hormone-inhibiting hormone (GHIH)
 
somatotropin release-inhibiting factor (SRIF)
somatotropin release-inhibiting hormone
2
lanreotideapprovedPhase 486108736-35-2
Synonyms:
Lanreotide
 
Lanreotide acetate
Somatuline Depot
3
Octreotideapproved, investigationalPhase 4, Phase 222383150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
 
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
4
MethyltestosteroneapprovedPhase 4, Phase 156358-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
5
Testosteroneapproved, investigationalPhase 4, Phase 156358-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
6
ClozapineapprovedPhase 41175786-21-02818
Synonyms:
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
5786-21-0
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
AC-280
AC1L1EJE
AC1Q3OPZ
AC1Q3ZWP
AKOS005064444
AR-1I2412
Asaleptin
BRD-K37289225-001-09-1
BRN 0764984
Bio1_000436
Bio1_000925
Bio1_001414
Bio2_000310
Bio2_000790
C 6305
C06924
C18H19ClN4
C6305_SIGMA
CAS-5786-21-0
CCRIS 9171
CHEBI:3766
CHEMBL42
CID2818
CLOZARIL
CPD000058365
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
Clozapine
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
Clozapinum
Clozapinum [INN-Latin]
Clozaril
Clozaril (TN)
D00283
D003024
DB00363
DivK1c_000343
EINECS 227-313-7
EU-0100276
FT-0082373
Fazaclo
Fazaclo ODT
HF-1854
HF1854
HMS1361P12
HMS1569E21
HMS1791P12
HMS1921C16
HMS1989P12
HMS2089L13
HMS2092I16
HMS501B05
 
HSDB 6478
I06-0047
InChI=1/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3
Iprox
KBio1_000343
KBio2_000310
KBio2_000599
KBio2_002878
KBio2_003167
KBio2_005446
KBio2_005735
KBio3_000619
KBio3_000620
KBio3_002979
KBioGR_000310
KBioGR_001336
KBioSS_000310
KBioSS_000599
KS-1166
L000195
L013417
LEX-123
LS-60881
LX 100-129
Leponex
Lepotex
Lopac-C-6305
MLS000028472
MLS001077282
MolPort-001-728-041
NCGC00015254-01
NCGC00015254-02
NCGC00015254-03
NCGC00015254-07
NCGC00015254-17
NCGC00022902-02
NCGC00022902-04
NCGC00022902-05
NCGC00022902-06
NCGC00022902-07
NCGC00022902-08
NCGC00022902-09
NCGC00022902-10
NCGC00022902-11
NCGC00022902-13
NINDS_000343
Prestwick0_000350
Prestwick1_000350
Prestwick_693
S2459_Selleck
SAM002548976
SMR000058365
SPBio_000798
SPBio_002340
SPECTRUM1500685
Spectrum2_000919
Spectrum3_001828
Spectrum4_000898
Spectrum_000139
Tocris-0444
UNII-J60AR2IKIC
W-801
clozapine
clozapine(tautomer)
7
MetforminapprovedPhase 4, Phase 21803657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
8Peripheral Nervous System AgentsPhase 423689
9AngiopeptinPhase 486
10Hypoglycemic AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 15896
11Antirheumatic AgentsPhase 410956
12
CurcuminPhase 4146458-37-7969516
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
C.I. Natural Yellow 3
CI Natural Yellow 3
Cucurmin
Curcuma
Curcumin
Curcumin I
Diferaloylmethane
Diferuloylmethane
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
Hydrastis
 
Indian saffron
Indian turmeric
Kacha haldi
Kurkumin [czech]
Merita earth
Natural yellow 3
Orange root
Safran D'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yo-kin
Zlut prirodni 3 [Czech]
13Analgesics, Non-NarcoticPhase 46501
14HormonesPhase 4, Phase 1, Phase 2, Early Phase 114415
15Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 1, Phase 2, Early Phase 113168
16Hormone AntagonistsPhase 4, Phase 1, Phase 2, Early Phase 113180
17Anti-Inflammatory Agents, Non-SteroidalPhase 44443
18Anti-Inflammatory AgentsPhase 410729
19AnalgesicsPhase 411733
20GABA AgentsPhase 41684
21Psychotropic DrugsPhase 46430
22Serotonin AgentsPhase 43156
23Tranquilizing AgentsPhase 44265
24Serotonin AntagonistsPhase 41409
25Central Nervous System DepressantsPhase 413403
26
SerotoninPhase 4362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
27Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
28Antineoplastic Agents, HormonalPhase 4, Phase 2, Phase 15592
29AndrogensPhase 4, Phase 11321
30Anabolic AgentsPhase 4, Phase 1513
31Insulin, Globin ZincPhase 4, Phase 2, Phase 3, Phase 14645
32insulinPhase 4, Phase 2, Phase 3, Phase 14646
33Testosterone 17 beta-cypionatePhase 4, Phase 1563
34
Testosterone enanthatePhase 4, Phase 1563315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
35Antipsychotic AgentsPhase 42401
36Testosterone undecanoatePhase 4, Phase 1563
37
DiazoxideapprovedPhase 2, Phase 322364-98-73019
Synonyms:
2H-1,2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide
364-98-7
7-Chloro-3-methyl-1lambda~4~,2,4-benzothiadiazin-1-ol 1-oxide
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido
7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido [Italian]
7-chloro-3-methyl-4H-1
AC1L1EZN
Aroglycem
BPBio1_000016
BRD-K73109821-001-05-2
BSPBio_000014
BSPBio_001307
BSPBio_002290
Bio1_000036
Bio1_000525
Bio1_001014
Bio2_000027
Bio2_000507
C06949
C8H7ClN2O2S
CAS-364-98-7
CBiol_001750
CHEBI:4495
CHEMBL181
CID3019
CPD000058392
D 9035
D00294
D003981
D9035_SIGMA
DB01119
Diazossido
Diazossido [DCIT]
Diazossido [Italian]
Diazoxide
Diazoxide (JAN/USP/INN)
Diazoxide [USAN:INN:BAN]
Diazoxido
Diazoxido [INN-Spanish]
Diazoxidum
Diazoxidum [INN-Latin]
Dizoxide
EINECS 206-668-1
EU-0100404
Eudemine
HMS1361B09
HMS1568A16
HMS1791B09
HMS1922L22
HMS1989B09
HMS2051P20
HMS2089L04
HMS2093N12
Hyperstat
Hyperstat (TN)
Hypertonalum
I06-2041
 
IDI1_033777
KBio2_000027
KBio2_002595
KBio2_005163
KBio3_000053
KBio3_000054
KBio3_001510
KBioGR_000027
KBioGR_001776
KBioSS_000027
LS-40410
Lopac-D-9035
Lopac0_000404
MLS000028459
MLS001076071
MolPort-003-666-772
MolPort-003-941-186
Mutabase
NCGC00015380-01
NCGC00015380-02
NCGC00015380-03
NCGC00015380-05
NCGC00015380-12
NCGC00024907-01
NCGC00024907-02
NCGC00024907-03
NCGC00024907-04
NCGC00024907-05
NCGC00024907-06
NCGC00024907-07
NCGC00024907-08
NSC 64198
NSC 76130
NSC-64198
NSC64198
NSC76130
Prestwick0_000087
Prestwick1_000087
Prestwick2_000087
Prestwick3_000087
Prestwick_163
Proglicem
Proglycem
SAM001246872
SMR000058392
SPBio_001953
SPECTRUM2300206
SRG 95213
SRG-95213
Sch 6783
Sch-6783
Spectrum3_000735
Spectrum4_001248
Tocris-0964
UNII-O5CB12L4FN
VU0239714-6
ZINC03872277
diazoxide
nchembio.150-comp49
nchembio.476-comp10
38
DopamineapprovedPhase 3, Phase 2, Phase 1383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
39Antihypertensive AgentsPhase 2, Phase 34207
40Vasodilator AgentsPhase 2, Phase 33543
41Dopamine AgentsPhase 3, Phase 2, Phase 13836
42DihydroxyphenylalaninePhase 3, Phase 2, Phase 1143
43
Exenatideapproved, investigationalPhase 1, Phase 2, Early Phase 1296141758-74-915991534
Synonyms:
141732-76-5
141758-74-9
286014-72-0
335149-21-8
AC 2993
AC 2993 LAR
AC 2993A
AC-2993
AC002993
AC2993
AC2993a
Bydureon
Byetta
 
C074031
CHEBI:490990
CHEMBL414357
Ex4 peptide
Exenatide
Exenatide Synthetic
Exenatide synthetic
Exendin 4
Exendin 4 (Heloderma suspectum)
Exendin-4
Extendin-4
LY2148568
Synthetic exendin-4
UNII-9P1872D4OL
44
Orlistatapproved, investigationalPhase 25296829-58-23034010
Synonyms:
(-)-Tetrahydrolipstatin
1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
111397-16-1
96829-58-2
AC-19012
AC1MHWQP
Alli
Alli, Xenical, Tetrahydrolipstatin, Orlistat
BIDD:GT0853
C055122
C29H53NO5
CHEMBL175247
CID3034010
CPD000466339
D04028
DB01083
FT-0082584
GlaxoSmithKline brand of orlistat
HMS2051I08
Hoffmann-La Roche brand of orlistat
KS-1183
L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
L-Leucine,N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
LS-178328
MLS000759448
MLS001423955
 
MLS002207022
MolPort-005-938-035
N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone
NCGC00165856-01
O4139_SIGMA
Orlipastat
Orlipastatum
Orlipastatum [INN-Latin]
Orlistat (USAN/INN)
Orlistat [USAN:INN]
R-212
Ro 18-0647/002
Ro 18-0647/008
Ro-18-0647
Roche brand of orlistat
S1629_Selleck
SAM001246637
SMR000466339
THLP
Tetrahydrolipstatin
UNII-95M8R751W8
Xenical
Xenical (TN)
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
nchembio.129-comp24
orlistat
45
Ethinyl EstradiolapprovedPhase 272857-63-65991
Synonyms:
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17 alpha-ethinyestradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17-alpha-Ethinyl-17-beta-estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17-alpha-ethynyl estradiol
17-ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-ethinylestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17alpha-Ethynylestradiol
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC-2169
AC1L1LK6
AI3-52941
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
BRN 2419975
Bio-0610
C07534
CCRIS 286
CHEBI:4903
CHEMBL691
CID5991
CPD000058319
Certostat
Chee-O-Gen
Chee-O-Genf
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
EINECS 200-342-2
EO
ETHINYLESTRADIOL
Effik Brand of Ethinyl Estradiol
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol [USP]
 
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl-Oestradiol Effik
Ethinyl-Oestranol
Ethinyl-oestranol
Ethinylestradiol
Ethinylestradiol (JP15/INN)
Ethinylestradiol Jenapharm
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Evra
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
HMS2051I19
HSDB 3587
Halodrin
Hemihydrate, Ethinyl Estradiol
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
LMST02010036
LS-231
Linoral
Lynoral
MLS000028479
MLS000758274
Marvelon
Menolyn
Menostar
Mercilon
Microfollin
Microfollin Forte
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
NSC-10973
NSC10973
Neo-Estrone
Nogest-S
Novestrol
OVULEN-21
OVULEN-28
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
Oviol
PUBERTAL ETHINYL ESTRADIOL STUDY
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
S1625_Selleck
SAM001247008
SGCUT00127
SMR000058319
Schering Brand of Ethinyl Estradiol
Spanestrin
Thiuram E
Thiuranide
UNII-423D2T571U
Vagifem
Varnoline
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
component of Demulen
component of Oracon
component of Ortrel
ethinyl estradiol
ethynyl estradiol
to_000048
46
NorethindroneapprovedPhase 29668-22-46230
Synonyms:
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
17-Ethinyl-19-nor-testosterone
17-Ethinyl-19-nortestosterone
17-Ethynyl-17-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (ACD/Name 4.0)
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-19-Nortestosterone
17-Hydroxy-(17alpha)-19-Norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-Norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-Nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17-alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-4-estren-17-ol-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-ethynyl-17beta-hydroxyestr-4-en-3-one
17.alpha.-Ethinyl-19-nortestosterone
17.alpha.-Ethynyl-19-nortestosterone
17.alpha.-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinyl-19-Nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-ethynyl-17-hydroxy-Estr-4-en-3-one
17alpha-ethynyl-17beta-hydroxy-19-Norandrost-4-en-3-one
17alpha-pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17α-ethinyl-19-nortestosterone
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyl testosterone
19-Nor-17-ethinyltestosterone
19-Nor-17.alpha.-ethynyltestosterone
19-Nor-17alpa-ethynyltestosterone
19-Nor-17alpha-Ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-Ethynylandrosten-17beta-ol-3-one
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17alpha-ethynyltestosterone
19-Nor-ethindrone
19-Nor-ethinyl--4,5-testosterone
19-Norethindrone
19-Norethinyltestosterone
19-Norethisterone
19-nor-17α-ethynyltestosterone
4-Estren-17alpha-ethynyl-17beta-ol-3-one
46525_FLUKA
46525_RIEDEL
68-22-4
A3564/0151191
AC-11100
AC1L1IDS
AC1L1M2R
AC1NWAOX
AC1O5EOU
AC1Q6OG5
AI3-26422
AKOS004119895
AR-1C1071
ARONIS24281
Activella
Anhydrohydroxynorprogesterone
Anovulatorio
Anovule
BB_NC-0600
BPBio1_000074
BRD-A39415247-001-02-1
BRD-K92073408-001-03-3
BRN 1915671
BSPBio_000066
BSPBio_002101
Brevicon
Brevinor
Brevinor 21
Brevinor 28
Brevinor-1 21
Brevinor-1 28
C05028
CCRIS 484
CHEBI:7627
CHEMBL1162
CID4536
CID5702093
CID6230
CID6432649
CPD000499579
Camila
Camila (TN)
Ciclovulan
Conceplan
Conludaf
Conludag
D00182
DB00717
Demulen
DivK1c_000553
EINECS 200-681-6
ENT
Errin
Estrinor
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylmortestosterone
Ethynylnortestosterone
Gencept
Genora
Gestest
HMS1568D08
HMS1920B10
HMS2090D21
HMS2091J10
HMS501L15
HSDB 3370
I06-0104
 
IDI1_000553
Jenest
Jenest-28
KBio1_000553
KBio2_001491
KBio2_004059
KBio2_006627
KBio3_001601
KBioGR_000637
KBioSS_001491
LMST02030097
LS-97425
Loestrin
MLS001076679
MLS001163874
MLS001304093
Menzol
Microneth
Micronett
Micronor
Micronor (TN)
Micronovum
Milli
Mini-Pe
Mini-pill
Minovlar
MolPort-002-507-131
MolPort-002-509-542
MolPort-002-728-977
MolPort-003-861-444
N.E.E
N.E.E.
N0449
N4128_SIGMA
NCGC00178820-01
NCGC00179669-01
NET
NINDS_000553
NSC-9564
NSC9564
Nelova
Nodiol
Nor-Q.D
Nor-Q.D.
Nor-QD
Nora-BE
Noraethisteronum
Noralutin
Norcept
Norcept-E
Norcolut
Norcolute
Noresthisterone
Norethadrone
Norethin
Norethin 1/35 E
Norethin 1/50 M
Norethindirone
Norethindrone
Norethindrone (USP)
Norethindrone Norethisterone
Norethindrone [USAN]
Norethisteron
Norethisterone
Norethisterone (JP15)
Norethisterone [Progestins]
Norethisteronum
Norethisteronum [INN-Latin]
Norethyndron
Norethynodron
Norethynodrone
Noretisterona
Noretisterona [INN-Spanish]
Noretisterone
Noretisterone [DCIT]
Norfor
Norgestin
Noriday
Noriday 28
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Norpregneninotone
Oprea1_606355
Orlest
Ortho 1 35
Ortho 7 7 7
Ortho-Novum 1 35
Ortho-Novum 1 50
Ortho-Novum 7 7 7
Ovysmen 0.5 35
Ovysmen 1 35
Prestwick0_000253
Prestwick1_000253
Prestwick2_000253
Prestwick3_000253
Prestwick_646
Primolut N
Primolut-N
Primolut-N (TN)
Proluteasi
SAM002564223
SC 4640
SMR000499579
SMR000718762
SPBio_001052
SPBio_002285
SPECTRUM1500437
ST094767
STK730956
STOCK1N-04274
Spectrum2_001066
Spectrum3_000521
Spectrum4_000079
Spectrum5_001198
Spectrum_001011
Synphase
Synphasic 28
Tri-Norinyl
Triella
Trinovum 21
UNII-T18F433X4S
Utovlan
Utovlar
WLN: L E5 B666 OV MUTJ E FQ F1UU1 -A&F
ZINC03814419
component of Noriday
norethindrone
47
Estradiolapproved, investigational, vet_approvedPhase 2131850-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
 
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
48
BenzocaineapprovedPhase 1, Phase 220161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
49
Sirolimusapproved, investigationalPhase 1, Phase 2194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
50
EverolimusapprovedPhase 1, Phase 21940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus

Interventional clinical trials:

(show all 42)
idNameStatusNCT IDPhase
1Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of InfancyUnknown statusNCT01070758Phase 4
2Curcumin for Type 2 Diabetic PatientsUnknown statusNCT01052597Phase 4
3Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement TherapyCompletedNCT02171390Phase 4
4Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic AbnormalitiesCompletedNCT02751307Phase 4
5Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short StatureTerminatedNCT00121875Phase 4
6Diazoxide In the Management Of Hypoglycemic NeonatesUnknown statusNCT00994149Phase 2, Phase 3
7Trial of Leptin Replacement Therapy in Patients With LipodystrophyCompletedNCT00896298Phase 2, Phase 3
818F-DOPA PET Imaging: an Evaluation of Biodistribution and SafetyRecruitingNCT03042416Phase 3
9Effects of Human Leptin ReplacementUnknown statusNCT00657605Phase 2
10Effects of Leptin Replacement in ChildrenUnknown statusNCT00659828Phase 2
11A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital HyperinsulinismCompletedNCT02604485Phase 2
12Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital HyperinsulinismCompletedNCT00571324Phase 1, Phase 2
13Effect of Exendin-(9-39) on Fasting Adaptation and Protein SensitivityCompletedNCT00897676Phase 1, Phase 2
14Sandostatine® LP and HyperinsulinismCompletedNCT00987168Phase 2
15Effect of Gelofusine on GLP1-receptor ImagingCompletedNCT02541734Phase 1, Phase 2
16Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) WomenCompletedNCT00704912Phase 2
17CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital HyperinsulinismRecruitingNCT02937558Phase 2
18Effect of Exendin-(9-39) On Glucose Requirements To Maintain EuglycemiaRecruitingNCT00835328Phase 1, Phase 2
19Sirolimus for the Treatment of HyperinsulinismRecruitingNCT02524639Phase 1, Phase 2
20Acupuncture or Metformin for Insulin Resistance in Women With PCOSRecruitingNCT02647827Phase 2
21Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic HypoglycemiaActive, not recruitingNCT01468454Phase 2
22Utility of [F-18] fluoroDOPA for Neonatal HyperinsulinismActive, not recruitingNCT00674440Phase 2
23Pasireotide in Hyperinsulinemic HypoglycemiaNot yet recruitingNCT03053284Phase 2
24Fluorodopa F 18 in Congenital HyperinsulinismRecruitingNCT02021604Phase 1
25Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)TerminatedNCT03118479Phase 1
26Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital HyperinsulinismUnknown statusNCT01819584
2768Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of NesidioblastosisUnknown statusNCT02560376Early Phase 1
28Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary SyndromeUnknown statusNCT01569425
29Towards Individualized Surgery in Non-focal Congenital HyperinsulinismCompletedNCT02108730
30Fat Metabolism in Pregnancy and Neonatal Heart Function in DiabetesCompletedNCT01346527
31Study of Metabolic Modifications in Children With Noonan SyndromeCompletedNCT02383316
32To Study Polycystic Ovary Syndrome in Taiwanese WomenCompletedNCT01256944
33Presentations of Hyperandrogenic Phenotypes in Taiwanese WomenCompletedNCT01940666
34Frequency of Metabolic Syndrome in Down Syndrome PatientsCompletedNCT00864461
35Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter SyndromeCompletedNCT00523835
36Phlebotomy and Polycystic Ovary SyndromeRecruitingNCT02460445
37Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal DevelopmentActive, not recruitingNCT01623934
38Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With OlanzapineActive, not recruitingNCT00512070
39Compassionate Use of SOM230 for Hyperinsulinemic/HypoglycemiaAvailableNCT02835131
4018F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic HypoglycemiaAvailableNCT01916148
41Study of the Use of [18F]-DOPA in Hyperinsulinemic HypoglycemiaAvailableNCT02533219
42Natural History Study of Patients With Excess AndrogenEnrolling by invitationNCT00250159

Search NIH Clinical Center for Hyperinsulinemic Hypoglycemia, Familial, 1

Genetic Tests for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Genetic tests related to Hyperinsulinemic Hypoglycemia, Familial, 1:

id Genetic test Affiliating Genes
1 Persistent Hyperinsulinemic Hypoglycemia of Infancy27

Anatomical Context for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

MalaCards organs/tissues related to Hyperinsulinemic Hypoglycemia, Familial, 1:

36
Brain, Pancreatic islet

Publications for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Variations for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

UniProtKB/Swiss-Prot genetic disease variations for Hyperinsulinemic Hypoglycemia, Familial, 1:

70 (show all 71)
id Symbol AA change Variation ID SNP ID
1ABCC8p.Gly716ValVAR_000100rs72559723
2ABCC8p.Arg1352ProVAR_008537rs28936370
3ABCC8p.Arg1420CysVAR_008539rs28938469
4ABCC8p.Arg1493TrpVAR_008540rs28936371
5ABCC8p.Arg74GlnVAR_008639rs72559734
6ABCC8p.His125GlnVAR_008640rs60637558
7ABCC8p.Val187AspVAR_008641rs137852672
8ABCC8p.Asn188SerVAR_008642rs797045213
9ABCC8p.Asn406AspVAR_008644rs72559728
10ABCC8p.Phe591LeuVAR_008646rs72559726
11ABCC8p.Thr1138MetVAR_008649rs201351976
12ABCC8p.Arg1214GlnVAR_008650rs367850779
13ABCC8p.Gly1378ArgVAR_008653
14ABCC8p.Gly1381SerVAR_008654rs773448052
15ABCC8p.Arg1393HisVAR_008655rs769279368
16ABCC8p.Gly1478ArgVAR_008656rs72559715
17ABCC8p.Val1360MetVAR_015007
18ABCC8p.Arg1436GlnVAR_015008rs387906407
19ABCC8p.Glu1506LysVAR_015009rs137852671
20ABCC8p.Leu1543ProVAR_015010rs72559713
21ABCC8p.Gly7ArgVAR_031349
22ABCC8p.Val21AspVAR_031350rs200670692
23ABCC8p.Phe27SerVAR_031351
24ABCC8p.Gly70GluVAR_031352
25ABCC8p.Arg74TrpVAR_031353rs201682634
26ABCC8p.Gly111ArgVAR_031355rs761749884
27ABCC8p.Ala116ProVAR_031356rs72559731
28ABCC8p.Met233ArgVAR_031357
29ABCC8p.Asp310AsnVAR_031358rs769569410
30ABCC8p.Cys418ArgVAR_031359rs67254669
31ABCC8p.Arg495GlnVAR_031360
32ABCC8p.Glu501LysVAR_031361rs372307320
33ABCC8p.Leu503ProVAR_031362
34ABCC8p.Leu508ProVAR_031363rs72559727
35ABCC8p.Pro551ArgVAR_031364
36ABCC8p.Arg620CysVAR_031365rs58241708
37ABCC8p.Phe686SerVAR_031366
38ABCC8p.Lys719ThrVAR_031367
39ABCC8p.Arg841GlyVAR_031368
40ABCC8p.Lys889ThrVAR_031369rs761862121
41ABCC8p.Ser956PheVAR_031370rs72559721
42ABCC8p.Thr1130ProVAR_031371
43ABCC8p.Leu1147ArgVAR_031372
44ABCC8p.Arg1214TrpVAR_031373rs139964066
45ABCC8p.Asn1295LysVAR_031374
46ABCC8p.Lys1336AsnVAR_031375rs67767715
47ABCC8p.Gly1342GluVAR_031376
48ABCC8p.Leu1349GlnVAR_031377
49ABCC8p.Lys1384GlnVAR_031378
50ABCC8p.Ser1386PheVAR_031379rs72559718
51ABCC8p.Gly1400ArgVAR_031380rs137852676
52ABCC8p.Arg1418HisVAR_031381
53ABCC8p.Leu1450ProVAR_031382
54ABCC8p.Ala1457ThrVAR_031383rs72559717
55ABCC8p.Asp1471HisVAR_031384
56ABCC8p.Asp1471AsnVAR_031385rs72559716
57ABCC8p.Arg1486LysVAR_031386
58ABCC8p.Arg1493GlnVAR_031387
59ABCC8p.Val1550AspVAR_031388
60ABCC8p.Leu1551ValVAR_031389
61ABCC8p.Leu511MetVAR_072940
62ABCC8p.Gly716AspVAR_072941
63ABCC8p.Glu824LysVAR_072942
64ABCC8p.Leu890ProVAR_072943
65ABCC8p.Gly1378SerVAR_072946
66ABCC8p.Ser1388TyrVAR_072947
67ABCC8p.Leu1389ProVAR_072948
68ABCC8p.Ala1457ValVAR_072949
69ABCC8p.Asn1480IleVAR_072950
70ABCC8p.Asp1505GluVAR_072951
71ABCC8p.Ile1511SerVAR_072952

Clinvar genetic disease variations for Hyperinsulinemic Hypoglycemia, Familial, 1:

5 (show all 68)
id Gene Variation Type Significance SNP ID Assembly Location
1ABCC8NM_ 000352.4(ABCC8): c.3509delT (p.Leu1170Argfs)deletionPathogenicrs587783169GRCh38Chr 11, 17404560: 17404560
2ABCC8NM_ 001287174.1(ABCC8): c.2147G> T (p.Gly716Val)SNVPathogenicrs72559723GRCh37Chr 11, 17448671: 17448671
3ABCC8NM_ 000352.4(ABCC8): c.4628T> C (p.Leu1543Pro)SNVLikely pathogenicrs72559713GRCh38Chr 11, 17393109: 17393109
4ABCC8NM_ 001287174.1(ABCC8): c.2800C> T (p.Arg934Ter)SNVPathogenic/ Likely pathogenicrs570388861GRCh38Chr 11, 17408415: 17408415
5ABCC8NM_ 000352.4(ABCC8): c.3124_ 3126delACCinsCAGCCAGGAACTG (p.Thr1042Glnfs)indelLikely pathogenicrs786204542GRCh38Chr 11, 17406924: 17406926
6ABCC8NM_ 000352.4(ABCC8): c.2857C> T (p.Gln953Ter)SNVLikely pathogenicrs541269678GRCh38Chr 11, 17407417: 17407417
7ABCC8NM_ 001287174.1(ABCC8): c.2509C> T (p.Arg837Ter)SNVPathogenic/ Likely pathogenicrs72559722GRCh38Chr 11, 17412716: 17412716
8ABCC8NM_ 000352.4(ABCC8): c.4411G> A (p.Asp1471Asn)SNVLikely pathogenicrs72559716GRCh37Chr 11, 17416719: 17416719
9ABCC8NM_ 000352.4(ABCC8): c.2116+2T> CSNVLikely pathogenicrs786204676GRCh38Chr 11, 17427865: 17427865
10ABCC8NM_ 000352.4(ABCC8): c.291-2A> GSNVLikely pathogenicrs786204695GRCh38Chr 11, 17470224: 17470224
11ABCC8NM_ 000352.4(ABCC8): c.2124_ 2127delGACT (p.Thr709Terfs)deletionLikely pathogenicrs786204717GRCh38Chr 11, 17427144: 17427147
12ABCC8NM_ 001287174.1(ABCC8): c.4163_ 4165delTCT (p.Phe1388del)deletionPathogenicrs151344624GRCh37Chr 11, 17417435: 17417437
13ABCC8NM_ 000352.4(ABCC8): c.1532T> C (p.Leu511Pro)SNVLikely pathogenicrs797045206GRCh37Chr 11, 17464365: 17464365
14ABCC8NM_ 000352.4(ABCC8): c.2117-1G> ASNVPathogenicrs797045207GRCh37Chr 11, 17448702: 17448702
15ABCC8NM_ 000352.4(ABCC8): c.239T> G (p.Met80Arg)SNVLikely pathogenicrs797045208GRCh37Chr 11, 17496484: 17496484
16ABCC8NM_ 000352.4(ABCC8): c.331G> A (p.Gly111Arg)SNVPathogenic/ Likely pathogenicrs761749884GRCh37Chr 11, 17491729: 17491729
17ABCC8NM_ 000352.4(ABCC8): c.4119+1G> ASNVPathogenicrs797045211GRCh38Chr 11, 17396915: 17396915
18ABCC8NM_ 000352.4(ABCC8): c.4516_ 4536dup21 (p.Asp1512_ Met1513insGluAlaThrAlaSerIleAsp)duplicationLikely pathogenicrs797045212GRCh37Chr 11, 17415822: 17415842
19ABCC8NM_ 000352.4(ABCC8): c.563A> G (p.Asn188Ser)SNVPathogenic/ Likely pathogenicrs797045213GRCh38Chr 11, 17463454: 17463454
20ABCC8NM_ 000352.4(ABCC8): c.4146T> G (p.Ser1382Arg)SNVLikely pathogenicrs886039877GRCh38Chr 11, 17395904: 17395904
21ABCC8NM_ 000352.4(ABCC8): c.4198G> A (p.Gly1400Arg)SNVLikely pathogenicrs137852676GRCh37Chr 11, 17417399: 17417399
22ABCC8NM_ 000352.4(ABCC8): c.4306C> T (p.Arg1436Ter)SNVPathogenic/ Likely pathogenicrs193922402GRCh37Chr 11, 17417158: 17417158
23ABCC8NM_ 000352.4(ABCC8): c.4451G> A (p.Gly1484Glu)SNVLikely pathogenicrs193922405GRCh37Chr 11, 17415907: 17415907
24ABCC8NM_ 000352.4(ABCC8): c.3748C> T (p.Arg1250Ter)SNVPathogenicrs1057516281GRCh37Chr 11, 17419891: 17419891
25ABCC8NM_ 000352.4(ABCC8): c.3574delG (p.Asp1192Metfs)deletionLikely pathogenicrs1057516317GRCh37Chr 11, 17424284: 17424284
26ABCC8NM_ 000352.4(ABCC8): c.4353G> A (p.Trp1451Ter)SNVLikely pathogenicrs1057516404GRCh37Chr 11, 17416777: 17416777
27ABCC8NM_ 000352.4(ABCC8): c.3525C> G (p.Tyr1175Ter)SNVLikely pathogenicrs1057516439GRCh38Chr 11, 17404544: 17404544
28ABCC8NM_ 000352.4(ABCC8): c.1671+1G> CSNVLikely pathogenicrs1057516509GRCh37Chr 11, 17453750: 17453750
29ABCC8NM_ 000352.4(ABCC8): c.2098_ 2099delAC (p.Thr700Hisfs)deletionLikely pathogenicrs1057516542GRCh37Chr 11, 17449431: 17449432
30ABCC8NM_ 000352.4(ABCC8): c.3108G> A (p.Trp1036Ter)SNVLikely pathogenicrs1057516585GRCh37Chr 11, 17428489: 17428489
31ABCC8NM_ 000352.4(ABCC8): c.2255+2T> CSNVLikely pathogenicrs1057516589GRCh37Chr 11, 17438475: 17438475
32ABCC8NM_ 000352.4(ABCC8): c.415delC (p.Leu139Cysfs)deletionLikely pathogenicrs1057516591GRCh38Chr 11, 17463602: 17463602
33ABCC8NM_ 000352.4(ABCC8): c.1630+1G> TSNVPathogenicrs773306994GRCh37Chr 11, 17464266: 17464266
34ABCC8NM_ 000352.4(ABCC8): c.795dupG (p.Leu266Alafs)duplicationLikely pathogenicrs1057516654GRCh37Chr 11, 17483157: 17483157
35ABCC8NM_ 000352.4(ABCC8): c.4474delG (p.Ala1492Profs)deletionLikely pathogenicrs1057516655GRCh37Chr 11, 17415884: 17415884
36ABCC8NM_ 000352.4(ABCC8): c.1603_ 1604insA (p.Ala535Aspfs)insertionLikely pathogenicrs1057516665GRCh37Chr 11, 17464293: 17464294
37ABCC8NM_ 000352.4(ABCC8): c.4021C> T (p.Gln1341Ter)SNVLikely pathogenicrs1057516718GRCh38Chr 11, 17397014: 17397014
38ABCC8NM_ 000352.4(ABCC8): c.2556+1G> ASNVLikely pathogenicrs749271190GRCh38Chr 11, 17412665: 17412665
39ABCC8NM_ 000352.4(ABCC8): c.1879delC (p.His627Metfs)deletionLikely pathogenicrs1057516860GRCh38Chr 11, 17428609: 17428609
40ABCC8NM_ 000352.4(ABCC8): c.4478G> A (p.Arg1493Gln)SNVLikely pathogenicrs746480424GRCh37Chr 11, 17415880: 17415880
41ABCC8NM_ 000352.4(ABCC8): c.3400-1G> ASNVLikely pathogenicrs576684889GRCh38Chr 11, 17404670: 17404670
42ABCC8NM_ 000352.4(ABCC8): c.4072_ 4073delAAinsT (p.Lys1358Cysfs)indelLikely pathogenicrs1057516890GRCh37Chr 11, 17418509: 17418510
43ABCC8NM_ 000352.4(ABCC8): c.1468-2A> CSNVLikely pathogenicrs1057516946GRCh38Chr 11, 17442884: 17442884
44ABCC8NM_ 000352.4(ABCC8): c.413-2A> GSNVLikely pathogenicrs1057517015GRCh38Chr 11, 17463606: 17463606
45ABCC8NM_ 000352.4(ABCC8): c.2683dupC (p.His895Profs)duplicationLikely pathogenicrs1057517019GRCh38Chr 11, 17410527: 17410527
46ABCC8NM_ 000352.4(ABCC8): c.4119+1delGdeletionLikely pathogenicrs1057517050GRCh37Chr 11, 17418462: 17418462
47ABCC8NM_ 000352.4(ABCC8): c.1467+2T> CSNVLikely pathogenicrs1057517128GRCh38Chr 11, 17443176: 17443176
48ABCC8NM_ 000352.4(ABCC8): c.692G> A (p.Trp231Ter)SNVLikely pathogenicrs1057517139GRCh37Chr 11, 17483260: 17483260
49ABCC8NM_ 000352.4(ABCC8): c.584dupA (p.Tyr195Terfs)duplicationPathogenicrs1057517199GRCh38Chr 11, 17461821: 17461821
50ABCC8NM_ 000352.4(ABCC8): c.220C> T (p.Arg74Trp)SNVLikely pathogenicrs201682634GRCh37Chr 11, 17496503: 17496503
51ABCC8NM_ 000352.4(ABCC8): c.3650+2T> ASNVLikely pathogenicrs1057517274GRCh38Chr 11, 17402659: 17402659
52ABCC8NM_ 000352.4(ABCC8): c.4120-1G> TSNVLikely pathogenicrs1057517406GRCh38Chr 11, 17395931: 17395931
53ABCC8NM_ 000352.4(ABCC8): c.2695-1G> CSNVLikely pathogenicrs1057517420GRCh37Chr 11, 17430065: 17430065
54ABCC8ABCC8, EX13DELdeletionPathogenic
55ABCC8ABCC8, 1-BP DUP, 512TduplicationPathogenic
56ABCC8ABCC8, IVS8, A-G, -1013SNVPathogenic
57ABCC8NM_ 001287174.1(ABCC8): c.4310G> A (p.Arg1437Gln)SNVPathogenicrs387906407GRCh37Chr 11, 17417157: 17417157
58ABCC8NM_ 001287174.1(ABCC8): c.3992-9G> ASNVPathogenicrs151344623GRCh37Chr 11, 17418602: 17418602
59ABCC8ABCC8, IVS, G-A, -1SNVPathogenic
60ABCC8ABCC8, BRANCH POINT, A-G, -20SNVPathogenic
61ABCC8ABCC8, EX35, G-ASNVPathogenic
62ABCC8NM_ 001287174.1(ABCC8): c.4058G> C (p.Arg1353Pro)SNVPathogenicrs28936370GRCh37Chr 11, 17418527: 17418527
63ABCC8NM_ 001287174.1(ABCC8): c.4261C> T (p.Arg1421Cys)SNVPathogenicrs28938469GRCh37Chr 11, 17417206: 17417206
64ABCC8NM_ 000352.4(ABCC8): c.4477C> T (p.Arg1493Trp)SNVPathogenic/ Likely pathogenicrs28936371GRCh37Chr 11, 17415881: 17415881
65ABCC8NM_ 001287174.1(ABCC8): c.4519G> A (p.Glu1507Lys)SNVPathogenicrs137852671GRCh37Chr 11, 17415842: 17415842
66ABCC8NM_ 000352.4(ABCC8): c.560T> A (p.Val187Asp)SNVPathogenicrs137852672GRCh37Chr 11, 17485004: 17485004
67ABCC8NM_ 001287174.1(ABCC8): c.4159_ 4161delTCC (p.Ser1387del)deletionPathogenicrs387906408GRCh37Chr 11, 17417439: 17417441
68ABCC8ABCC8, -64C-GSNVPathogenic

Expression for genes affiliated with Hyperinsulinemic Hypoglycemia, Familial, 1

About this section
Search GEO for disease gene expression data for Hyperinsulinemic Hypoglycemia, Familial, 1.

Pathways for genes affiliated with Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

GO Terms for genes affiliated with Hyperinsulinemic Hypoglycemia, Familial, 1

About this section

Sources for Hyperinsulinemic Hypoglycemia, Familial, 1

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet